Great find imtesty. The first 8 or 9 pages of the March 2021 paper may to a large extent explain the 8 year lead that DM has referred to over the years. Page 15 brings it home for us;
RVX-208 or apabetalone was originally discovered during the screening for apoAI mRNA inducers in cultured hepatocytes [187] and currently represents the most promising BET inhibitor in clinical studies.
tada